6.17
price up icon161.44%   3.81
after-market After Hours: 5.93 -0.24 -3.89%
loading

Cervomed Inc Stock (CRVO) Latest News

pulisher
06:12 AM

Chardan lifts CervoMed stock rating to Buy, targets $14 - Investing.com India

06:12 AM
pulisher
04:48 AM

CervoMed upgraded to Buy from Neutral at Chardan - TipRanks

04:48 AM
pulisher
10:18 AM

EU's tariffs will be 'devastating' for spirits sector, industry says - info-mods.com

10:18 AM
pulisher
09:30 AM

The maker of Roomba has ‘substantial doubt’ about surviving - CNN

09:30 AM
pulisher
07:19 AM

CervoMed (NASDAQ:CRVO) Given New $15.00 Price Target at Roth Mkm - Defense World

07:19 AM
pulisher
07:05 AM

CervoMed Inc.'s (NASDAQ:CRVO) Price Is Right But Growth Is Lacking - Simply Wall St

07:05 AM
pulisher
03:10 AM

CervoMed’s (CRVO) Buy Rating Reaffirmed at D. Boral Capital - Defense World

03:10 AM
pulisher
Mar 11, 2025

CervoMed Shares Business and Financial Updates Online - TipRanks

Mar 11, 2025
pulisher
Mar 11, 2025

Brookline raises CervoMed stock rating to buy, sets $16 target - Investing.com

Mar 11, 2025
pulisher
Mar 11, 2025

Mineralys aims to raise $250M; Coherus discloses layoffs - Endpoints News

Mar 11, 2025
pulisher
Mar 11, 2025

Brookline raises CervoMed stock rating to buy, sets $16 target By Investing.com - Investing.com UK

Mar 11, 2025
pulisher
Mar 11, 2025

Trump says he’ll buy a Tesla to support Elon Musk, whose companies are struggling - CNN

Mar 11, 2025
pulisher
Mar 11, 2025

Brookline Capital Upgrades CervoMed to Buy From Hold, Price Target is $16 -March 11, 2025 at 08:46 am EDT - Marketscreener.com

Mar 11, 2025
pulisher
Mar 11, 2025

CervoMed price target raised to $15 from $7 at Roth MKM - TipRanks

Mar 11, 2025
pulisher
Mar 11, 2025

CervoMed reports positive results from dementia trial - The Pharma Letter

Mar 11, 2025
pulisher
Mar 11, 2025

Dementia drug neflamapimod shows positive phase 2b trial results - PharmaTimes

Mar 11, 2025
pulisher
Mar 10, 2025

Who is Mark Carney, the crisis-handling former central bank governor turned Canada’s next leader? - CNN

Mar 10, 2025
pulisher
Mar 10, 2025

CervoMed announces results from extension phase of RewinD-LB study - TipRanks

Mar 10, 2025
pulisher
Mar 10, 2025

CervoMed Reports Positive Phase 2b Trial Results - TipRanks

Mar 10, 2025
pulisher
Mar 10, 2025

CervoMed Inc. Reports Positive Results from Extension Phase of Phase 2b RewinD-LB Study for Neflamapimod in Dementia with Lewy Bodies - Nasdaq

Mar 10, 2025
pulisher
Mar 10, 2025

CervoMed Announces Positive Results from the Extension - GlobeNewswire

Mar 10, 2025
pulisher
Mar 10, 2025

CVS is opening smaller stores that only have pharmacies - CNN

Mar 10, 2025
pulisher
Mar 10, 2025

Analysts Set CervoMed Inc. (NASDAQ:CRVO) PT at $37.43 - Defense World

Mar 10, 2025
pulisher
Feb 26, 2025

The US Postal Service is more efficient than you think. Privatizing it could cause problems for many - CNN

Feb 26, 2025
pulisher
Feb 25, 2025

Musk’s Starlink gets FAA contract, raising new conflict of interest concerns - CNN

Feb 25, 2025
pulisher
Feb 24, 2025

MSNBC announces major lineup overhaul, new Washington bureau as Joy Reid exits company - CNN

Feb 24, 2025
pulisher
Feb 20, 2025

CervoMed (NASDAQ:CRVO) Raised to Buy at D. Boral Capital - Armenian Reporter

Feb 20, 2025
pulisher
Feb 19, 2025

Boral Capital raises CervoMed stock to Buy, sets $10 target By Investing.com - Investing.com Australia

Feb 19, 2025
pulisher
Feb 19, 2025

Why CervoMed (CRVO) Is Advancing Today - Yahoo Canada Finance

Feb 19, 2025
pulisher
Feb 19, 2025

This Workday Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday - Benzinga

Feb 19, 2025
pulisher
Feb 19, 2025

This NetApp Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Wednesday - Benzinga

Feb 19, 2025
pulisher
Feb 19, 2025

Boral Capital raises CervoMed stock to Buy, sets $10 target - Investing.com

Feb 19, 2025
pulisher
Feb 17, 2025

How Are Things Looking For CervoMed Inc (NASDAQ: CRVO) For The Short Term? - Stocks Register

Feb 17, 2025
pulisher
Feb 13, 2025

CervoMed Inc. (NASDAQ:CRVO) Receives $42.00 Average PT from Brokerages - Defense World

Feb 13, 2025
pulisher
Feb 11, 2025

BIO CEO 2025: Cognition CEO debates policy while advancing CT-1812 - BioWorld Online

Feb 11, 2025
pulisher
Feb 04, 2025

Perigon Wealth Management LLC Makes New Investment in CervoMed Inc. (NASDAQ:CRVO) - Defense World

Feb 04, 2025
pulisher
Feb 01, 2025

CervoMed Provides Update on Neflamapimod DLB Program as - GlobeNewswire

Feb 01, 2025
pulisher
Jan 31, 2025

CervoMed reports progress in dementia drug trial - MSN

Jan 31, 2025
pulisher
Jan 31, 2025

CervoMed Updates on Neflamapimod Trials for Dementia - TipRanks

Jan 31, 2025
pulisher
Jan 31, 2025

CervoMed reports progress in dementia drug trial By Investing.com - Investing.com UK

Jan 31, 2025
pulisher
Jan 31, 2025

Clinical Trial Setback: CervoMed's Dementia Drug Gets Second Chance with Enhanced Formula - StockTitan

Jan 31, 2025
pulisher
Jan 29, 2025

CervoMed to Present at the 8th International Lewy Body Dementia Conference - GlobeNewswire

Jan 29, 2025
pulisher
Jan 29, 2025

Major Breakthrough in Lewy Body Dementia Treatment: CervoMed Reveals Game-Changing Clinical Data - StockTitan

Jan 29, 2025
pulisher
Jan 24, 2025

CervoMed Inc. (NASDAQ:CRVO) Stock Holdings Lifted by Barclays PLC - Defense World

Jan 24, 2025
pulisher
Jan 21, 2025

Roth MKM Initiates Coverage of CervoMed (CRVO) with Buy Recommendation - MSN

Jan 21, 2025
pulisher
Jan 19, 2025

CervoMed Inc. (NASDAQ:CRVO) Receives $42.00 Average Price Target from Analysts - Defense World

Jan 19, 2025
pulisher
Jan 13, 2025

AWM Investment Company, Inc. Reduces Stake in CervoMed Inc - GuruFocus.com

Jan 13, 2025
pulisher
Jan 11, 2025

CervoMed (STU:DP8) Momentum Rank : 8 (As of Jan. 11, 2025) - GuruFocus.com

Jan 11, 2025
pulisher
Jan 09, 2025

Geode Capital Management LLC Raises Holdings in CervoMed Inc. (NASDAQ:CRVO) - Defense World

Jan 09, 2025
pulisher
Jan 09, 2025

Barclays PLC Acquires 5,919 Shares of CervoMed Inc. (NASDAQ:CRVO) - Defense World

Jan 09, 2025
pulisher
Jan 04, 2025

Brookline Capital Initiates Coverage of CervoMed (CRVO) with Buy Recommendation - MSN

Jan 04, 2025
pulisher
Jan 02, 2025

State Street Corp Boosts Stake in CervoMed Inc. (NASDAQ:CRVO) - Defense World

Jan 02, 2025
pulisher
Dec 25, 2024

Analysts Set CervoMed Inc. (NASDAQ:CRVO) Price Target at $42.00 - Defense World

Dec 25, 2024
pulisher
Dec 20, 2024

HC Wainwright Brokers Reduce Earnings Estimates for CervoMed - Defense World

Dec 20, 2024
pulisher
Dec 18, 2024

Enhanced Cognition: Lewy body dementia phase II pumps stock - BioWorld Online

Dec 18, 2024
pulisher
Dec 17, 2024

HC Wainwright & Co. Downgrades CervoMed (CRVO) - MSN

Dec 17, 2024
$35.01
price up icon 3.70%
$307.09
price up icon 0.88%
$32.85
price up icon 1.20%
$19.91
price up icon 7.62%
$100.31
price up icon 1.95%
biotechnology ONC
$249.84
price up icon 1.68%
Cap:     |  Volume (24h):